If you are attending the Joint Irish-UK Endocrine Meeting 2024, we recommend that you join Prof. Kassim Javid to hear proven results from the ADOPT study. Nanox.AI’s bone solution Increased Identification of patients with vertebral compression fractures, an early sign of Osteoporosis.
Nanox AI
Hospitals and Health Care
Transforming patient care with the power of AI
עלינו
Nanox AI is lighting up new pathways for smart population healthcare management with AI-based solutions, identifying patients at risk of having chronic disease and enabling the start of preventative care pathways. Integrated delivery networks and payers benefit from this technology with more accurate risk-adjustment, timely intervention, and improved quality of health services, while significantly reducing the associated costs. Nanox AI enables better, fairly reimbursed population health management and wellbeing for larger patient populations. #population health #AI #machine learning #digitalhealth #medicalimaging
- אתר אינטרנט
-
https://www.nanox.vision/ai
קישור חיצוני עבור Nanox AI
- תעשייה
- Hospitals and Health Care
- גודל החברה
- 51-200 עובדים
- משרדים ראשיים
- Kibutz Shfayim
- סוג
- בבעלות פרטית
- הקמה
- 2014
- התמחויות
מיקומים
-
הראשי
קבלת הוראות הגעה
Shfayim Commercial Center floor2
Kibutz Shfayim, IL
עובדים ב- Nanox AI
-
Prashant Malik
General Partner Tykhe Block Ventures | Angel investor | Entrepreneur | Advisor | Technologist.
-
Yulia Eidlin
Senior QA Engineer at Nanox AI
-
Pini Ben Elazar
CEO at Laser Team | Pioneering Nano-Thulium Laser Technology & Medical Innovation
-
Upjeet Singh
Managing Director at NanoX AI Labss
עדכונים
-
Cardiovascular disease is the leading cause of death worldwide. Nanox.AI’s Cardiac Solution detects coronary artery calcification to identify patients at risk of CAD. Early detection can save lives. Discover how our AI-powered solution is transforming cardiac care: https://lnkd.in/ee8i5-z9 #WorldHeartDay #HeartHealth #AIinHealthcare #CardiovascularDiseasePrevention #MedicalInnovation
-
-
Nanox AI פרסם מחדש את זה
Chad, a landlocked Central African country, has faced severe challenges from climate change, with record flooding in 2022 displacing thousands and straining its fragile healthcare system. Over 6 million people face food insecurity, and healthcare access is limited, especially in rural areas. Last week, we had the privilege of hosting representatives from the Chad Embassy in response to their request for support. We showcased Nanox.ARC, an affordable imaging solution, alongside the Nanox.CONNECT, showcasing its ultra-portability to suit their specific requirements. We are delighted to explore potential opportunities to provide healthcare solutions to Chad. Learn more about Nanox’s solutions here: https://www.nanox.vision/
-
-
Today, we proudly rang the closing bell at Nasdaq to celebrate the four-year anniversary of Nanox’s IPO from this past August, and our continued growth in the medical imaging technology sector. "We are honored to have the opportunity to commemorate our success as a publicly traded company following our four-year anniversary this past August and recent analyst day earlier today in New York City," said Erez Meltzer, CEO of Nanox. "Today, we celebrate the collective efforts of the Nanox team and the strong foundation we have built for continued growth, patient and provider satisfaction, and value creation for our shareholders.” https://lnkd.in/ekh7A4Ex #Nanox #Nasdaq #MedTech #Innovation #ClosingBell
-
-
On Friday, our team hosted an Analyst Day, presenting recent advancements and future plans. We proudly introduced our next product - Nanox.ARC X, the next version of our 3D multi-source digital tomosynthesis system featuring expanded capabilities, which is not yet regulatorily approved. The event also featured key highlights from our clinical trials. The presentation is available on our website. We extend our sincere gratitude to everyone who participated in this event. Your engagement and support continue to drive our innovation forward in medical imaging technology. #Nanox #MedicalImaging #HealthTech #Innovation
-
-
Today, Nanox will visit the Nasdaq MarketSite in Times Square. In honor of the occasion, Erez Meltzer, Chief Executive Officer and acting Chairman, will ring the Closing Bell. Friday, September 20, 2024 – 3:45 p.m. to 4:00 p.m. ET https://lnkd.in/ey5BgdZu
-
-
Latest news coverage from BioWorld News See how BioWorld discussed the recent FDA 510(k) clearance of the upgraded Nanox.AI cardiac solution, HealthCCSng V2.0. Learn what our CEO Erez Meltzer had to say about our AI cardiac solution’s expanded capabilities: https://lnkd.in/eStYz22D #AIinHealthcare #CardiovascularHealth #MedicalResearch #MedicalInnovation
-
-
Nanox.AI solutions analyze routine CT scans performed for any clinical indication to help identify patients with asymptomatic or undetected findings suggestive of chronic disease. Six in ten adults in the US suffer from at least one chronic disease. Chronic diseases are often diagnosed at advanced stages, when the patient's condition has become critical and more difficult to treat. Early detection can improve preventative healthcare. Learn more about our preventive care for aging populations: https://lnkd.in/ee8i5-z9 #HealthyAgingMonth #AIinHealthcare #PreventiveCare #MedicalInnovation
-
-
Some fractures can be missed on conventional X-rays, especially in areas of complex anatomic structure such as the wrist or ankle. The cast obscures some of the anatomy, and in many cases the patient is asked to remove the cast before the imaging creating discomfort for the patient. These fractures can be seen more clearly when captured through digital tomosynthesis, and the effect of the cast is minimal - hence it is unnecessary to remove the cast. Learn more about how Nanox.ARC can improve your imaging results: https://lnkd.in/ecXjXF7r
-
Nanox.AI solutions analyze routine CT scans performed for any clinical indication to help identify patients with asymptomatic or undetected findings suggestive of chronic disease “AI can see complex patterns in the imaging data and subtle signs in imaging that the human eye can miss. Maybe a human radiologist can perceive some of the small details, but they do not have an easy way to quantify it, so it is not extremely useful,” American College of Radiology CEO Dana H. Smetherman, MD, said to Radiology Business. Read the full article here: https://lnkd.in/gMkDpyGY #AIinHealthcare #MedicalInnovation
-